Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front
MMWFortschrittederMedizin 145(27-28): 63
2003
ISSN/ISBN: 1438-3276 PMID: 14587198 Document Number: 553457
Document emailed within 1 workday
Related Documents
Schattenkirchner, M. 2001: New basic therapeutic drugs from the viewpoint of evidence-based therapy Zeitschrift für Rheumatologie 60(6): 473-4762001: Osteoporosis therapy with bisphosphonates. Once weekly is enough MMW Fortschritte der Medizin 143(44): 58
Takada, J.; Iba, K.; Yamashita, T. 2011: Diagnostic imaging of treatment in osteoporosis: SERM Clinical Calcium 21(7): 1047-1055
Chang, S.Fang.; Yang, R.Sen. 2014: Determining the cut-off point of osteoporosis based on the osteoporosis self-assessment tool, body mass index and weight in Taiwanese young adult women Journal of clinical nursing 23(17-18): 2628-2635
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Fassbender, W.J.; Stumpf, U.C.; Jockenhövel, F. 2006: Pharmacotherapy of osteoporosis: evidence-based clinical practice Medizinische Klinik 101(Suppl 1): 173-177
Meltzer, E.; Dolev, E. 2001: Inflammatory bowel disease and osteoporosis--an evidence-based connection Harefuah 140(7): 590
Maillefert, J.F.; Sibilia, J.; Bertin, P.; Tavernier, C. 1999: Bisphosphonates in rheumatoid arthritis (osteoporosis excluded) Revue du Rhumatisme 66(10): 442-445
Homik, J.E.; Cranney, A.; Shea, B.; Tugwell, P.; Wells, G.; Adachi, J.D.; Suarez-Almazor, M.E. 1999: A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis Journal of Rheumatology 26(5): 1148-1157
Chen, R.; Wang, C.; Yan, Q.-Y. 2014: Observation on therapeutic effect of polycystic ovary syndrome of damp-phlegm constitution treated with embedding therapy on back-shu points and front-mu points combined with needle-pricking therapy on Sifeng (EX-UE 10) Zhongguo Zhen Jiu 34(4): 355-358
Aksaranugraha, S. 2015: BMD Changes Following 2-Year Treatment of Osteoporosis by using BMK to Monitor the Dose of Bisphosphonates Journal of the Medical Association of Thailand 98 Suppl. 8: S8-12
Eiken, P.A.; Abrahamsen, B. 2017: Osteoporosis treatment can be discontinued based on an individual assessment Ugeskrift for Laeger 179(2)
Sheldon, T.A.; Raffle, A.; Watt, I. 1996: Department of Health shoots itself in the hip. Why the report of the Advisory Group on Osteoporosis undermines evidence based purchasing Bmj 312(7026): 296-297
Brouillet, E. 2000: Animal models of Huntington's disease: from basic research on neuronal death to assessment of new therapeutic strategies Functional Neurology 15(4): 239-251
Clayson, D.B. 1995: Risk assessment for carcinogenesis promoting agents: need for a weight of all the evidence approach Progress in Clinical and Biological Research 391: 359-367
Mulligan, S.; White, B.P.; Arthanat, S. 2014: An examination of occupation-based, client-centered, evidence-based occupational therapy practices in new Hampshire Otjr: Occupation Participation and Health 34(2): 106-116
Goddard, A.F.; Spiller, R.C. 1997: In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents Antimicrobial Agents and ChemoTherapy 41(6): 1246-1249
Robinson, D.S.; Roberts, D.L.; Copp, J.E.; Schwiderski, U. 1989: Diagnostic and clinical assessment issues in the development and therapeutic evaluation of psychopharmacologic agents Psychopharmacology Bulletin 25(1): 9-15
Broderick, G.A. 1998: Evidence based assessment of erectile dysfunction International Journal of Impotence Research 10(Suppl 2): S64
Dominici, C.; Petrucci, F.; Alimonti, A.; La Torre, F.; Cifani, A.; Caroli, S. 1995: Platinum-based antineoplastic agents: biomedical applications and therapeutic aspects Annali Dell'istituto Superiore di Sanita 31(2): 289-294